News
Faces of Future: Dr. Ingmar Schuster
Ingmar Schuster, scientist, co-founder, and CEO of Exazyme, pioneers AI-driven protein development at Freie Universität Berlin’s Startup Villa. He unveils how Exazyme was born from talks with Thomas Happe’s research team, evolving into a business idea. Schuster sees Exazyme revolutionizing industries reliant on chemical reactions and enzymes, enhancing sustainability and efficiency. He discusses the hurdles for German scientist-entrepreneurs, advocating for a shift in investor attitudes and administrative processes to nurture scientific entrepreneurship.
Read full article here: https://zukunftsorte.berlin/faces-of-future/ingmar-schuster/
ZUKUNFTSORTE BERLIN, 24th October 2022
More from Exazyme
- News/
Exazyme partners with Ginkgo Bioworks and becomes part of the Ginkgo Technology Network
Exazyme partners with Ginkgo Bioworks, joining the Ginkgo Technology Network to empower R&D teams with AI-driven protein engineering solutions.
Read More
- Knowledge/
Painful Intelligence: Aapo Hyvärinen on the Concept of Suffering, Drawing Parallels between Humans and AI, and Conclusions for AI Ethics.
Explore Dr. Aapo Hyvärinen’s perspective on the concept of suffering, the parallels between humans and AI, and potential conclusion for AI ethics.
Read More